Meeting Coverage

For tailored therapy selection and result optimization in diffuse large B-cell lymphoma (DLBCL),...

Results from the MIRROR RCT trial, presented at the 2022 American Society of Nephrology’s Kidney...

Gout flares occurred in 18% of patients with comorbid gout who were hospitalized for COVID-19,...

IgG-based elimination diets using a novel diagnostic tool to guide therapy may be beneficial to...

For patients with gout, urate-lowering therapy (ULT) increases the risk of hospitalizations within...

Individuals with hypercholesterolemia who had higher levels of campesterol experienced...

Limited research has been done on outcomes after the return of secondary findings in large-scale...

Tafolecimab provided significant, durable decreases in low-density lipoprotein cholesterol (LDL-C)...

VICTORION-INCEPTION is a phase IIIb, randomized, parallel-group, open-label, multicenter, US-based...

The principal finding from a 4-year open-label extension study of inclisiran—a small interfering...

For patients with refractory/relapsed acute myeloid leukemia (AML), total therapy, as compared...

Compared with their White counterparts, gout is more prevalent in Black adults, according to the...

Compared with patients with gout who did not experience a cardiovascular (CV) event, those who did...

In a randomized-controlled trial, cognitive rehabilitation therapy (CRT) and mindfulness-based...

Discontinuing natalizumab during the first trimester of pregnancy increased relapse risk during...

Do disease-modifying therapies (DMTs) in everyday practice delay the progression of disease in...

New research suggests that not only is MS preceded by Epstein-Barr virus (EBV) infection, but it...

Immune ablation with autologous hematopoietic stem cell transplantation (AHSCT) was not superior...

Disease progression independent of relapse activity (PIRA) was found to be less frequent in...

Treatment with ravulizumab was highly effective in reducing risk for relapse in patients with...